The Bacteria in Your Mouth Are a Window Into Your Whole Body
You probably think of your mouth as separate from the rest of your health. You brush your teeth, floss once in a while, see your dentist annually. It's a local problem in a local space. But that's not how biology works. Your mouth is connected to everything. And the bacteria living there—your oral microbiome—are telling you a story about your heart, your brain, and your metabolic future.
The evidence is now overwhelming. Porphyromonas gingivalis, a pathogenic bacteria common in periodontal disease, has been found in the brains of 96% of Alzheimer's disease patients in the research conducted by Dominy and colleagues (2019). Not 50%. Not 70%. Ninety-six percent. That's in Science Advances, a high-impact journal. The bacteria appears in amyloid plaques—the hallmark pathology of Alzheimer's disease. The connection is no longer theoretical.
This is why your dentist isn't doing you a favour by cleaning your teeth. Your dentist is, in a very real sense, preventing neurodegenerative disease. And yet most people treat dental health as cosmetic, as an afterthought, as something nice to have if you can afford it.
The mechanism is straightforward. Pathogenic oral bacteria produce lipopolysaccharide, or LPS, a gram-negative endotoxin. When these bacteria are present in periodontal pockets and diseased gum tissue, the endotoxin crosses the epithelial barrier, enters the bloodstream, and triggers systemic inflammation. That inflammation—if chronic—contributes to atherosclerosis, metabolic dysfunction, and neurodegeneration.
P. gingivalis and the Alzheimer's Connection
Let's go deeper into the Dominy mechanism, because this is where the biology becomes specific and actionable. P. gingivalis secretes virulence factors called gingipains—proteases that degrade host proteins and trigger immune responses. When the bacteria is present in the periodontal pockets, gingipains are released into the bloodstream.
In the Dominy 2019 study, researchers used monoclonal antibodies against gingipains to identify the bacterial protein in Alzheimer's tissue. They found it. They also showed that in a mouse model, introducing P. gingivalis led to increased amyloid-beta production and tau phosphorylation—the two cardinal pathological features of Alzheimer's disease.
Cortexyme, a biotech company, has developed a gingipain inhibitor called COR388 based on this research. Phase 2 trials in Alzheimer's patients are ongoing. The hypothesis is that blocking gingipains could slow cognitive decline. We don't have a miracle drug yet. But we have evidence that periodontal bacteria are causative, not just correlative, in Alzheimer's pathogenesis.
What does this mean for you now? It means that if you have gum disease, you have a direct biological link to neuroinflammation. The best time to prevent this is before plaque forms. The second-best time is today.
Oral Bacteria in Atherosclerotic Plaques: A Direct Cardiovascular Link
If you have ever wondered why cardiologists should care about your teeth, here's the answer. Oral anaerobes—the same bacteria that cause gingivitis and periodontitis—have been cultured directly from atherosclerotic plaques in coronary arteries. This isn't an association. Researchers have isolated living bacteria from arterial tissue.
Beck and colleagues demonstrated that periodontal disease is an independent risk factor for coronary artery disease. The mechanism involves bacterial translocation. When your gums bleed—and most people with periodontal disease have bleeding gums—bacteria enter the bloodstream. They circulate. They seed themselves in areas of vascular injury and inflammation. The resulting biofilm, embedded in the arterial wall, drives atherosclerotic progression.
The evidence is dose-dependent. Mild gingivitis carries modest risk. Moderate periodontitis carries higher risk. Severe periodontitis—the kind that leads to tooth loss—correlates with a substantially elevated incidence of myocardial infarction and stroke. In some studies, the risk elevation is comparable to smoking or elevated cholesterol.
This is why your GP should be asking about your teeth. They usually don't. Cardiologists rarely do. But the biology is clear: your mouth microbiome is a window into your coronary risk, and it's modifiable.
The Bidirectional Relationship Between Oral Microbiota and Diabetes
Diabetes and periodontal disease have a complicated relationship. They're not just correlated. They're causative in both directions. Hyperglycaemia promotes an oral microbiota composition that favours pathogenic organisms. Once established, dysbiotic oral microbiota impair glucose tolerance and drive systemic inflammation that worsens diabetes control.
The mechanism involves toll-like receptors, or TLRs. Oral pathogens express patterns that TLRs recognise. When TLRs are activated—chronically, systemically—they drive a pro-inflammatory state. That state includes insulin resistance. Experimental evidence shows that oral LPS promotes insulin resistance in hepatocytes and adipocytes through TLR4 signalling.
Studies of people with type 2 diabetes show that those with periodontal disease have worse glycaemic control—higher HbA1c—than those without periodontal disease. Some studies suggest that treating periodontal disease improves HbA1c by 0.4-0.5%, which is clinically meaningful. For context, that's equivalent to adding a metformin or a GLP-1 agonist.
The converse is also true. People with poor glycaemic control have more rapid periodontal disease progression and higher tooth loss rates. The two conditions feed each other. Treating one optimizes the other.
Oral Microbiota and Birth Outcomes
Periodontal disease during pregnancy carries consequences that extend far beyond the mother. Chronic periodontitis is associated with preterm birth and low birth weight. The mechanism appears to involve the dissemination of oral pathogens and their LPS to the placenta, triggering inflammatory mediators that can induce labour prematurely.
Studies in pregnant women show that those with untreated periodontitis have a significantly higher incidence of preterm birth. Some studies suggest that treatment of periodontitis during pregnancy reduces preterm birth risk, though the evidence here is less conclusive than the association itself.
This is relevant to any woman of reproductive age. Your oral microbiota are not just your problem. They affect your offspring's developmental trajectory. One more reason to take this seriously.
What Actually Works: Evidence-Based Strategies
Oil Pulling: Probably Not
Oil pulling—the practice of swishing coconut or sesame oil in your mouth for 15-20 minutes daily—has become popular in functional medicine circles. The claim is that the oil removes toxins and bacteria. The evidence is weak. Small studies show modest reductions in plaque and gingivitis, but they're poorly controlled and lack blinding. There's no mechanistic reason why oil swishing would remove pathogenic bacteria in periodontal pockets where they're embedded in biofilm. Oil pulling probably does no harm, but your time is better spent elsewhere.
Flossing: Stronger Than You'd Think
Flossing is often dismissed as ineffective because large randomised controlled trials show minimal benefit for plaque reduction in people with healthy gums. But those trials miss the point. Flossing prevents the initiation of gum disease. Once disease is established, flossing's benefit is limited—you need deeper intervention. But prevention is what matters. Daily flossing reduces your risk of developing gingivitis by 40-60% in prospective studies.
The technique matters. Most people floss incorrectly—sawing vertically rather than curving around the tooth and using an up-and-down motion. If you floss, do it properly. A water flosser works if you won't use string floss. The goal is to remove plaque from the subgingival space before bacteria form biofilm and produce LPS.
Mouthwash: Nuanced
Chlorhexidine mouthwash is excellent at reducing plaque and gingivitis. It works. The problem is that it kills both pathogenic and commensal bacteria. Chronic use of chlorhexidine can shift your oral microbiota toward pathogenic organisms once you stop using it. It's useful for acute gum inflammation or as a short-term intervention, but not daily long-term.
The same applies to most antimicrobial mouthwashes. They're not selective. They deplete your beneficial oral bacteria—organisms that compete with pathogens and produce compounds that regulate inflammation. You need discrimination. Killing everything is not a strategy.
Tongue Scraping: Data Supports It
Your tongue harbours massive numbers of bacteria. Studies show that morning tongue scraping reduces bacterial load by 40-60%. More importantly, it preferentially removes pathogenic gram-negative anaerobes. If you do it gently—you're not cleaning a tile floor—you avoid damaging the epithelium. Daily tongue scraping appears to reduce oral LPS and improve periodontal health. This is one of the few oral hygiene practices supported by both mechanistic and epidemiological evidence.
Systemic Strategies: Probiotics and Prebiotics
The evidence for oral probiotics is emerging but not yet decisive. Some strains of Lactobacillus and Streptococcus appear to outcompete pathogens in the oral biofilm. Studies show reductions in plaque and gingivitis, but the effect sizes are modest—usually 15-30% improvement over standard care. The benefit seems stronger when you combine probiotics with mechanical removal (flossing, brushing, professional cleaning).
Prebiotics—compounds that selectively feed beneficial bacteria—show promise. Certain polyphenols and short-chain fatty acid precursors appear to shift the oral microbiota composition toward non-pathogenic species. But this is still early-stage research.
Why Most Dentists Still Don't Talk About Microbiota
You'll go to your dentist. They'll clean your teeth. They'll say "floss more." They won't mention P. gingivalis or gingipains or the Alzheimer's connection. Why? Partly because dental education lags behind the microbiology literature. Partly because it's easier to talk about plaque and bleeding gums than to explain systemic inflammation and neurodegeneration. Partly because dentistry and medicine are still siloed disciplines that don't talk to each other.
This is changing. Cardiologists are beginning to understand that a periodontal exam is part of cardiovascular risk assessment. Neurology is watching the gingipain research closely. But for now, you probably need to bridge the gap yourself. If you have signs of periodontal disease—bleeding gums, bad breath, loose teeth—don't think of it as a cosmetic problem. Think of it as a systemic inflammatory condition that needs addressing.
Your Action: Specific and Measurable
First, get a proper dental assessment. If you have any gum bleeding or recession, you have disease. Stage it. Know the degree of your periodontal problem. That determines treatment intensity.
Second, establish mechanical removal: twice-daily brushing with a soft brush (hard bristles damage gums), daily flossing (or water flossing), and daily tongue scraping. This is non-negotiable.
Third, consider short-term chlorhexidine rinse (0.12% twice daily for 2 weeks) if you have active inflammation, then transition to gentler alternatives. Ask your dentist about oral probiotics if you're at high risk (family history of Alzheimer's, existing cardiovascular disease, or diabetes).
Fourth, get professional cleaning every 3-6 months if you have any sign of disease. This is where your dentist removes plaque and calculus you can't remove yourself. It works.
Finally, understand that your mouth is not separate. Your oral microbiota are a leading indicator of brain health, cardiovascular health, and metabolic health. Treat them accordingly.